A-to-I RNA editing and cancer: From pathology to basic science

Angela Gallo, Silvia Galardi     Pages 135 - 139
View affiliations

  Abstract: In eukaryotes mRNA transcripts are extensively processed by different post-transcriptional events such as alternative splicing and RNA editing in order to generate many different mRNAs from the same gene, increasing the transcriptome and then the proteome. The most frequent RNA editing mechanism in mammals involves the conversion of specific adenosines into inosines by the ADAR family of enzymes. This editing event can change both the sequence and the secondary structures of RNA molecules, with important consequences on both the final proteins and regulatory RNAs. Alteration in RNA editing has been connected to numerous human pathologies and recent studies have demonstrated its importance in tumor progression.

View article preview
If you are seeking permission to republish your own work or portions of it, Landes Bioscience grants it freely (via our License to Transfer or the CC-BY-NC license if your paper is published using the OA model). There is no need to secure rights from Landes Bioscience or The Copyright Clearance Center.

All other permissions may be secured through The Copyright Clearance Center.
A-to-I RNA editing and cancer: From pathology to basic science
Creative Commons License
This is an Open Access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may redistributed, reproduced and reused for non-commercial purposes, provided the original source is properly cited.